Fatty acids but not dexamethasone are essential inducers for chick adipocyte differentiation in vitro.
The present study was carried out to clarify the direct effect of fatty acids (FAs) on chick (Gallus gallus) adipocyte differentiation in the absence of dexmethasone (DEX), a commonly used as strong inducer for adipocyte differentiation. Adipocyte differentiation was initiated by maintaining confluent cell in serum-free medium supplemented with FAs. Upon exposure to FAs, glycerol-3-phosphate dehydrogenase activity (GPDH) as adipocyte differentiation marker rapidly increased, and was significantly higher in chick adipocyte than in control cell. The morphology of the FAs-treated cell changed from fibroblast-like to polygon, and the cells accumulated many cytoplasmic lipid droplets as estimated by Oil red O staining. Neither insulin nor bovine serum albumin, as substitutes for serum, had an effect on chick adipocyte differentiation. The FAs-treated cell had a higher protein and mRNA expression levels for peroxisome proliferator-activated receptor-gamma (PPARgamma), a master regulator of differentiation, compared with untreated cell. In FAs-treated cell, the mRNA expression levels of adipocyte-specific genes, such as CCAAT/enhancer binding protein-alpha (C/EBP alpha) and adipocyte fatty acid-binding protein (aP2) were higher than in control cell. These results indicated that FAs, but not DEX, are essential inducers for chick adipocyte differentiation by elevating PPARgamma expression.
Matsubara
Yoshiyuki
Y
Laboratory of Cell and Tissue Biology, Graduate School of Bioresource Sciences, Nihon University, Kanagawa, Japan.
Endo
Tsuyoshi
T
Kano
Koichiro
K
D017667:Adipocytes / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000235:genetics; D002417:Cattle; D002454:Cell Differentiation / Q000187:drug effects; D002645:Chickens / Q000033:anatomy & histology* / Q000235:genetics; D016895:Culture Media, Serum-Free; D017931:DNA Primers / Q000235:genetics; D003907:Dexamethasone / Q000494:pharmacology; D050556:Fatty Acid-Binding Proteins / Q000235:genetics; D005227:Fatty Acids / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D008297:Male; D047495:PPAR gamma / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012710:Serum Albumin, Bovine / Q000494:pharmacology
D022763:CCAAT-Enhancer-Binding Protein-alpha; D016895:Culture Media, Serum-Free; D017931:DNA Primers; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids; D007328:Insulin; D047495:PPAR gamma; D012333:RNA, Messenger; D012710:Serum Albumin, Bovine; D003907:Dexamethasone